Temixys

Product manufactured by Celltrion Usa, Inc.

Application Nr Approved Date Route Status External Links
NDA211284 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Temixys Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection In Adult And Pediatric Patients Weighing At Least 35 Kg. Temixys, A Combination Of Two Nucleoside Reverse Transcriptase Inhibitors (Lamivudine And Tenofovir Disoproxil Fumarate), Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection In Adults And Pediatric Patients Weighing At Least 35 Kg. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments